Melanoma and Skin Cancer Trials Limited
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Melanoma and Skin Cancer Trials Limited sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Melanoma and Skin Cancer Trials Limited: 3 sponsored US clinical trials, 1 recruiting.
Melanoma and Skin Cancer Trials Limited sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Cutaneous Melanoma by AJCC V7 Stage, with 1 trials.
Upper-quartile sponsor footprint
Melanoma and Skin Cancer Trials Limited sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT03860883
MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT02385214
Neurotropic Melanoma of the Head and Neck
NCT00975520
Therapeutic Areas
What is open in the Melanoma and Skin Cancer Trials Limited pipeline
1 recruiting of 3 indexed (33% open); 1 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Cutaneous Melanoma by AJCC V7 Stage (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Melanoma and Skin Cancer Trials Limited: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Melanoma and Skin Cancer Trials Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Melanoma and Skin Cancer Trials Limited page
3 registered trials is a research-attention snapshot, not an endorsement of Melanoma and Skin Cancer Trials Limited or any single study.
- 1 of Melanoma and Skin Cancer Trials Limited's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cutaneous Melanoma by AJCC V7 Stage is the condition Melanoma and Skin Cancer Trials Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cutaneous Melanoma by AJCC V7 Stage trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Melanoma and Skin Cancer Trials Limited pipeline card: 3 registered trials from official public datasets.Report a data error.